88 related articles for article (PubMed ID: 26733157)
41. Pluripotency factor Nanog is tumorigenic by deregulating DNA damage response in somatic cells.
Kim J; Liu Y; Qiu M; Xu Y
Oncogene; 2016 Mar; 35(10):1334-40. PubMed ID: 26073077
[TBL] [Abstract][Full Text] [Related]
42. Inhibition of stearoyl-coA desaturase selectively eliminates tumorigenic Nanog-positive cells: improving the safety of iPS cell transplantation to myocardium.
Zhang L; Pan Y; Qin G; Chen L; Chatterjee TK; Weintraub NL; Tang Y
Cell Cycle; 2014; 13(5):762-71. PubMed ID: 24394703
[TBL] [Abstract][Full Text] [Related]
43. Hypoxia-induced immortalization of primary cells depends on Tfcp2L1 expression.
Otero-Albiol D; Santos-Pereira JM; Lucena-Cacace A; Clemente-González C; Muñoz-Galvan S; Yoshida Y; Carnero A
Cell Death Dis; 2024 Feb; 15(2):177. PubMed ID: 38418821
[TBL] [Abstract][Full Text] [Related]
44. Role of Nanog in the maintenance of marrow stromal stem cells during post natal bone regeneration.
Bais MV; Shabin ZM; Young M; Einhorn TA; Kotton DN; Gerstnefeld LC
Biochem Biophys Res Commun; 2012 Jan; 417(1):211-6. PubMed ID: 22142851
[TBL] [Abstract][Full Text] [Related]
45. Concise Review: NANOG in Cancer Stem Cells and Tumor Development: An Update and Outstanding Questions.
Jeter CR; Yang T; Wang J; Chao HP; Tang DG
Stem Cells; 2015 Aug; 33(8):2381-90. PubMed ID: 25821200
[TBL] [Abstract][Full Text] [Related]
46. Knockout of 4.1B triggers malignant transformation in SV40T-immortalized mouse embryo fibroblast cells.
Wang Z; Zhang J; Zeng Y; Sun S; Zhang J; Zhang B; Zhu M; Ouyang R; Ma B; Ye M; An X; Liu J
Mol Carcinog; 2017 Feb; 56(2):538-549. PubMed ID: 27312663
[TBL] [Abstract][Full Text] [Related]
47. NANOG helps cancer cells escape NK cell attack by downregulating ICAM1 during tumorigenesis.
Saga K; Park J; Nimura K; Kawamura N; Ishibashi A; Nonomura N; Kaneda Y
J Exp Clin Cancer Res; 2019 Oct; 38(1):416. PubMed ID: 31619256
[TBL] [Abstract][Full Text] [Related]
48. The pluripotency factor nanog promotes breast cancer tumorigenesis and metastasis.
Lu X; Mazur SJ; Lin T; Appella E; Xu Y
Oncogene; 2014 May; 33(20):2655-64. PubMed ID: 23770853
[TBL] [Abstract][Full Text] [Related]
49. The Developmental Origins of Cancer: A Review of the Genes Expressed in Embryonic Cells with Implications for Tumorigenesis.
Balachandran S; Narendran A
Genes (Basel); 2023 Feb; 14(3):. PubMed ID: 36980876
[TBL] [Abstract][Full Text] [Related]
50. Normal Somatic Mutations in Cancer Transformation.
Wijewardhane N; Dressler L; Ciccarelli FD
Cancer Cell; 2021 Feb; 39(2):125-129. PubMed ID: 33220180
[TBL] [Abstract][Full Text] [Related]
51. NANOG expression in human development and cancerogenesis.
Grubelnik G; Boštjančič E; Pavlič A; Kos M; Zidar N
Exp Biol Med (Maywood); 2020 Mar; 245(5):456-464. PubMed ID: 32041418
[TBL] [Abstract][Full Text] [Related]
52. Mutant Clones in Adjacent Normal Epithelium Limit Early Tumorigenesis.
Cancer Discov; 2021 Dec; 11(12):2958. PubMed ID: 34686529
[TBL] [Abstract][Full Text] [Related]
53. The Anterior Eye Chamber as a Visible Medium for In Vivo Tumorigenicity Tests.
Inagaki E; Arai E; Hatou S; Sayano T; Taniguchi H; Negishi K; Kanai Y; Sato Y; Okano H; Tsubota K; Shimmura S
Stem Cells Transl Med; 2022 Aug; 11(8):841-849. PubMed ID: 35666752
[TBL] [Abstract][Full Text] [Related]
54. The roles of NANOG in tumorigenesis.
Kim J; Yu S; Xu Y
Mol Cell Oncol; 2018; 5(3):e1074334. PubMed ID: 30250875
[TBL] [Abstract][Full Text] [Related]
55. Nanog Predicts Poor Prognosis in Human Pancreatic Cancer and Is Downregulated by QingyihuaJi Formula in Pancreatic Cancer Stem Cells.
Gao S; Pan Y; Song L; Dong L; Weng LI; Wang P; Hua Y; Chen Z; Liu L
Evid Based Complement Alternat Med; 2016; 2016():7028289. PubMed ID: 27829864
[TBL] [Abstract][Full Text] [Related]
56. Cell competition: Clonal competition protects against early tumorigenesis.
D'Ambrogio J; Hill L; Hogan C
Curr Biol; 2022 Jan; 32(1):R52-R54. PubMed ID: 35015999
[TBL] [Abstract][Full Text] [Related]
57. The role of polyploidy in tumorigenesis: confusion versus reality.
Liu J
Med Oncol; 2023 Sep; 40(10):291. PubMed ID: 37658944
[TBL] [Abstract][Full Text] [Related]
58. Skip to the end: metastasis before tumorigenesis.
Nobre AR; Boire A
Nat Genet; 2022 Dec; 54(12):1774-1775. PubMed ID: 36369288
[No Abstract] [Full Text] [Related]
59. Fibroblasts fuel intestinal tumorigenesis.
Wang D; DuBois RN
Cell Res; 2020 Aug; 30(8):635-636. PubMed ID: 32494022
[No Abstract] [Full Text] [Related]
60. Enhanced OCT4 transcriptional activity substitutes for exogenous SOX2 in cellular reprogramming.
Marthaler AG; Adachi K; Tiemann U; Wu G; Sabour D; Velychko S; Kleiter I; Schöler HR; Tapia N
Sci Rep; 2016 Jan; 6():19415. PubMed ID: 26762895
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
